12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Celularity (CELU) saw a 44.7% increase, while NovoCure (NVCR) rose by 24.15%. Jasper Therapeutics (JSPR) and Nuvectis Pharma (NVCT) also saw upward movements of 22.18% and 14.85%, respectively. Bullfrog AI Hldgs (BFRG) and Venus Concept (VERO) stocks rose by 14.74% and 14.28%. On the downside, Aravive (ARAV) dropped by 43.2%, Processa Pharma (PCSA) by 26.35%, and ZyVersa Therapeutics (ZVSA), 60 Degrees (SXTP), Cano Health (CANO), and MAIA Biotechnology (MAIA) also experienced declines.
January 18, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Celularity's stock surged by 44.7%, with a market cap of $52.8 million.
The significant surge in stock price indicates strong investor interest, which could lead to continued short-term momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
NovoCure's shares increased by 24.15%, with a market value of $1.6 billion.
A substantial increase in share price often leads to further investor interest, potentially driving the price up in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Aravive's shares decreased by 43.2%, with a market cap of $4.6 million.
A sharp decline in stock price could lead to negative sentiment and further short-term selling pressure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100